Discover 3,097 paid clinical trials in Worcester, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,097
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
for
Small Cell Lung Cancer (SCLC),
Location: Boston MA, New Haven CT, Baltimore MD, Fairfax VA,
Sponsor: Phanes Therapeutics
Sex: All
Age: 18+
Code: NCT05652686
Phase1, Phase2, Recruiting
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
for
Multiple Myeloma
Location: Boston MA, New York NY, Philadelphia PA, Montreal,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06106945
Phase1, Phase2, Recruiting
Evaluation of Safety and Efficacy of Bixdo Ultra Compact Water Flosser
for
Plaque Induced Gingivitis
Location: Boston MA
Sponsor: Tufts University
Sex: All
Age: 18 - 70
Code: NCT06352645
Recruiting
Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer
PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
for
Androgen Axis Suppression, Prostatectomy, Prostate Cancer
Location: Boston MA, New York NY, Chicago IL, Kansas City KS,
Sponsor: M.D. Anderson Cancer Center
Sex: Male
Age: 18+
Code: NCT06274047
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
"Prapela® SVS Incubator Pad for Apnea of Prematurity
for
Apnea of Prematurity
Location: Boston MA, Birmingham AL
Sponsor: Tufts Medical Center
Sex: All
Age: 0
Code: NCT06374147
Recruiting
Child and Adolescent Registry for Participants With Narcolepsy
for
Narcolepsy
Location: Boston MA, Manhasset NY, Philadelphia PA, Danville PA,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 0 - 17
Code: NCT04899947
Recruiting
A Natural History Study in Participants With Congenital Myasthenic Syndromes (CMS) Due to Mutations in DOK7, MUSK, AGRN, or LRP4
for
Congenital Myasthenic Syndrome
Location: Boston MA, Philadelphia PA, Ottawa, Columbus OH,
Sponsor: argenx
Sex: All
Age: 2+
Code: NCT06078553
Recruiting
A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas
for
Relapsed/Refractory Non-Hodgkin Lymphoma
Location: Boston MA, New York NY, Rochester MN, Tampa FL,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06090539
Phase1, Phase2, Recruiting
Home-Based tDCS Treatment Of Major Depressive Disorder
for
Major Depressive Disorder (MDD)
Location: Boston MA
Sponsor: Sooma Medical Inc
Sex: All
Age: 22 - 70
Code: NCT06976697
Recruiting
Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset
A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations
for
Metastatic Colorectal Cancer, KRAS G12C Mutations
Location: Boston MA, Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06412198
Phase1, Phase2, Recruiting
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
for
Advanced or Metastatic ER+ HER2- Breast Cancer (mBC),
Location: Boston MA, Grand Rapids MI, Nashville TN, Sarasota FL,
Sponsor: Olema Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06784193
Phase1, Recruiting
A Study of GMA301 in Subjects With Pulmonary Arterial Hypertension
for
Pulmonary Arterial Hypertension
Location: Boston MA
Sponsor: Gmax Biopharm LLC.
Sex: All
Age: 18 - 70+
Code: NCT04503733
Phase1, Recruiting
Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.
for
Crohn Disease
Location: Charlestown MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18 - 70+
Code: NCT06252493
Recruiting
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy